Skip to main content

Seely Lynn

In the past year, 6 open-market sale filings worth $353.1K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$353.1K
6 filings
Net
−$353.1K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Seely Lynn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LYEL Lyell Immunopharma, Inc.

President and CEO9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 25, 2026 (view filing)4:06 PM ETAug 214 daysSeely LynnPresident and CEOSSale−9.59K$15.54−$149.0K−13.0%63.9K after
Aug 11, 2026 (view filing)4:07 PM ETAug 101 daySeely LynnPresident and CEOSSale−390$14.34−$5.59K−0.5%73.5K after
Jun 15, 2026 (view filing)May 1135 daysLateSeely LynnPresident and CEOSSale−388$18.91−$7.34K−0.5%73.9K after
Feb 12, 2026 (view filing)Feb 111 daySeely LynnPresident and CEOSSale−7.46K$23.39−$174.4K−9.1%74.3K after
Feb 11, 2026 (view filing)Feb 101 daySeely LynnPresident and CEOSSale−438$23.12−$10.1K−0.5%81.7K after
Nov 12, 2025 (view filing)Nov 102 daysSeely LynnPresident and CEOSSale−412$16.11−$6.64K−0.6%67.2K after
Aug 22, 2025 (view filing)Aug 211 daySeely LynnPresident and CEOSSale−7.26K$10.54−$76.5K−9.7%67.6K after
Aug 13, 2025 (view filing)Aug 11-122 daysSeely LynnPresident and CEOSSale−797$10.43−$8.32K−2.2%34.8K after2 lots
Mar 18, 2025 (view filing)Mar 144 daysSeely LynnPresident and CEOPPurchase+175.0K$0.61+$106.8K+32.6%712.5K after